IceCure Medical

About:

IceCure is a medical device company focusing on minimally-invasive tumor therapy for women’s health and interventional oncology.

Website: http://icecure-medical.com

Twitter/X: IceCureMedical

Top Investors: Alpha Capital Anstalt, Epoch Investment Partners, Giza Venture Capital, Rosario Capital LTD, Clover Wolf and Clover Alpha

Description:

IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, IceCure’s core technology is based on cryoablation. Its proprietary third-generation technology uses freezing temperatures (liquid nitrogen) to effectively destroy tumors safely, quickly, and painlessly, without the need for surgery. Commercially available in the U.S.A., Europe, Hong-Kong, Thailand, Singapore and South- Central America, its flagship system, ProSense™, uses ultrasound imaging to guide a small probe (thin hollow needle) into the tumor. The easy-to-use ProSense™ cryoablation procedure enables full physician control and can be performed in less than 30 minutes in the comfort of a doctor’s office. As a proven solution for the treatment of fibroadenomas (benign breast tumors), the ProSense system is also indicated for use in the fields of general surgery, oncology, gynecology and urology.